Genomic alterations in small cell lung cancer and their clinical relevance

Podobne zapisy

• Clinical correlation of extensive-stage small-cell lung cancer genomics
  od: Dowlati, A., i wsp.
  Wydane: (2016)
• Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer
  od: Wildey, Gary, i wsp.
  Wydane: (2014)
• RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
  od: Sakre, Nneha, i wsp.
  Wydane: (2016)
• CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer
  od: Lindner, Daniel J., i wsp.
  Wydane: (2020)
• Relevance of genetic alterations in squamous and small cell lung cancer
  od: Sabari, Joshua K., i wsp.
  Wydane: (2017)